4.5 Article

A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV® in healthy 6 Months-45 years aged participants

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study

An-Wen Xiong et al.

Summary: The recombinant EGF-CRM197 therapeutic cancer vaccine is safe, well-tolerated, and can induce a robust neutralizing antibody response in patients with advanced solid tumors, leading to extended progression-free survival.

FRONTIERS IN ONCOLOGY (2021)

Article Immunology

An open-label, comparative, single dose, clinical Phase I study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults

Seuk Keun Choi et al.

Summary: The study assessed the safety, tolerability, and immunogenicity of an injectable typhoid conjugate vaccine in healthy Filipino adults, demonstrating higher immune protection and better safety profile of the vaccine. The findings suggest that the vaccine is effective in terms of immunogenicity and safety, with the recommended dose of 25 μg of Vi-CRM197 conjugate showing promising results.

VACCINE (2021)

Article Immunology

Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23)

Jeff Fairman et al.

Summary: This study successfully developed a 24-valent PCV using a proprietary cell-free protein synthesis platform, which showed promising immunogenicity with conjugate-like immune responses to all 24 serotypes. The novel technology has the potential to improve serotype coverage compared to traditional PCVs.

VACCINE (2021)

Review Microbiology

Vaccines to Prevent Meningitis: Historical Perspectives and Future Directions

Mark R. Alderson et al.

Summary: Globally, efforts are being made to control meningitis through vaccination, but challenges still exist in prevention, such as restrictions, incomplete coverage, and unaffordable vaccines.

MICROORGANISMS (2021)

Article Medicine, General & Internal

Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children

Priyanka D. Patel et al.

Summary: Among Malawian children, the Vi-TCV vaccine resulted in a lower incidence of blood culture-confirmed typhoid fever compared to the control vaccine.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Infectious Diseases

Surveillance of Salmonella enterica serovar Typhi in Colombia, 2012-2015

Paula Diaz-Guevara et al.

PLOS NEGLECTED TROPICAL DISEASES (2020)

Review Immunology

Global Typhoid Fever Incidence: A Systematic Review and Meta-analysis

Christian S. Marchello et al.

CLINICAL INFECTIOUS DISEASES (2019)

Article Medicine, General & Internal

Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal

Mila Shakya et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Medicine, General & Internal

Vaccines for preventing typhoid fever (Review)

Rachael Milligan et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Article Tropical Medicine

Prevalence and characterization of Salmonella among humans in Ghana

Linda Aurelia Andoh et al.

TROPICAL MEDICINE AND HEALTH (2017)

Review Medicine, Research & Experimental

Through the looking glass: understanding non-inferiority

Jennifer Schumi et al.

TRIALS (2011)

Article Multidisciplinary Sciences

Salmonella Pathogenesis and Processing of Secreted Effectors by Caspase-3

C. V. Srikanth et al.

SCIENCE (2010)

Article Immunology

Vaccines against typhoid fever

Carlos A. Guzman et al.

VACCINE (2006)

Review Medicine, General & Internal

Typhoid fever

CM Parry et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)